Outcomes More Promising for Primary Biliary Cirrhosis Patients Responsive to Ursodeoxycholic Acid

Primary-Biliary-Cirrhosis“Patients with primary biliary cirrhosis who had an increased aspartate transaminase/platelet ratio index faced future risk for adverse events, regardless of their biochemical response to ursodeoxycholic acid, in a recent study.”

The ultimate conclusion of the study was:

“According to the researchers, their study demonstrated “that APRI at diagnosis, and/or after 1 year, is able to independently predict adverse events in patients with [PBC], even when adjusting for treatment exposure and UDCA-response.”

The researchers suggested that clinicians would benefit from the availability of better stratification tools in their clinical practices.””

Post courtesy of Healio

 

See the #1 Liver Cirrhosis Diet Plan Here!

Leave a Reply

Your email address will not be published. Required fields are marked *

Outcomes More Promising for Primary Biliary Cirrhosis Patients Responsive to Ursodeoxycholic Acid

by Jim time to read: <1 min
0